Henan Lingrui Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥12.32 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	14.79
Forward PE	13.46
Price to Sales TTM	CN¥3.10
Price to Book MRQ	CN¥3.61
Enterprise to Revenue	2.89
Enterprise to EBITDA	12.42

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	21.14%
Operating Margin	20.88%
Return on Assets TTM	9.52%
Return on Equity TTM	25.94%

Income Statement

Revenue TTM	CN¥3,783,076,608
Revenue per Share TTM	CN¥6.68
Quarterly Revenue Growth	10.40%
Gross Profit TTM	CN¥3,047,119,360
EBITDA	CN¥904,272,865
Net Income to Common TTM	CN¥799,610,240
Diluted EPS TTM	CN¥1.40
Quarterly Earnings Growth YoY	9.80%

Balance Sheet

Total Cash MRQ	CN¥1,359,426,048
Total Cash per Share MRQ	CN¥2.40
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	15.99
Current Ratio MRQ	1.08
Book Value per Share MRQ	CN¥5.74

Cash Flow

Operating Cash Flow TTM	CN¥1,016,202,432
Levered Free Cash Flow TTM	CN¥526,417,248

600285 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	567,115,486
Float Shares	436,065,038
Avg 10 Volume	4,912,989
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	23.10%
% Held by Institutions	17.10%

Stock Price Summary

Beta	0.10
Fifty Two Week Low	CN¥19.83
Fifty Two Week High	CN¥24.94
Fifty Two Week Change	-3.86%
Day 50 MA	CN¥22.03
Day 200 MA	CN¥22.73

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.60
Forward Annual Dividend Yield	17.38%
Trailing Annual Dividend Rate	CN¥0.90
Trailing Annual Dividend Yield	4.35%
Payout Ratio	64.19%
Dividend Date
Ex Dividend Date	2025-06-20
Last Split Factor
Last Split Date	2014-07-02